In SCLC, 80% of cases exhibit high expression of achaete‐scute homolog 1 (ASCL1) and neurogenic differentiation factor 1 (NEUROD1), which are genes involved in transcriptional regulation. This evidence concerns the gene ASCL1 and small cell lung carcinoma.